Business Wire Feed
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the appointment of Ryan Koors to Vice President, Investor Relations, effective May 7, 2026. Mr. Koors will report to Johnson & Johnson’s Executive more...
The Biggest Predictor of Business Growth Is Behavior
New IDEO research reveals a gap in the behaviors that most drive growth: long-term vision, rapid experimentation, and team autonomy—with only 10% of leaders saying their company excels at the combination.SAN FRANCISCO--(BUSINESS WIRE)--IDEO, the global more...
Elevance Health’s Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
INDIANAPOLIS--(BUSINESS WIRE)--As small businesses continue to face rising healthcare costs, Elevance Health’s affiliated health plans are delivering solutions that help employers offer competitive benefits, improve health outcomes, and keep costs more affordable and more predictable. more...
Scribe Therapeutics to Highlight Engineered CRISPR Platform Advances and Lead Cardiometabolic Pipeline at ASGCT and EAS Congress 2026
ASGCT oral presentations to showcase recent development in engineering highly specific and potent CRISPR gene editing and epigenetic silencing technologies Late-breaking EAS oral presentation to report latest preclinical data for PCSK9-silencing therapy STX-1150 for ASCVD more...
UberDoc Health Technologies Announces Strategic Partnership with XY.AI Labs to Expand Physician Network and Advance AI-Driven Practice Support
Partnership connects UberDoc's direct-pay specialist marketplace with XY.AI Labs' agentic platform, giving independent practices a vetted path to integrating AI and direct payBOSTON--(BUSINESS WIRE)--UberDoc Health Technologies Corp. (CSE: APPT | FSE: 4KL0), the direct-pay healthcare more...
CGT Global Appoints Charlotte Ivancic to Board of Advisors, Strengthening Strategic Leadership in Cell and Gene Therapy Policy and Market Access
RENO, Nev.--(BUSINESS WIRE)--CGT Global, a leading accelerator of innovation, implementation and access to cell and gene therapies, announced today the appointment of Charlotte Ivancic to its Board of Advisors. Ms. Ivancic brings more than 25 more...
Natera to Report its First Quarter Results on May 7, 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its first quarter ended March 31, 2026, after the market closes on more...
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026
SAN DIEGO--(BUSINESS WIRE)--#5hmC--ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, today announced its presentation lineup for the upcoming Digestive Disease Week® (DDW) 2026 conference in Chicago, taking place more...
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference
Direct, sequence-perfect clonal DNA up to 50 kb is empowering customers to expand their design space and innovate without compromiseEMERYVILLE, Calif.--(BUSINESS WIRE)--#50kb--Ansa Biotechnologies, Inc., the trusted partner for DNA synthesis, today announced its lineup of more...
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its more...
ViaLase to Present Multiple Scientific Papers at the 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
ALISO VIEJO, Calif.--(BUSINESS WIRE)--#ARVO2026--ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that it will present new scientific research during the 2026 Association for Research in Vision and more...
Strand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer
Veteran biotech investment banker to lead corporate strategy and capital formation as Strand scales programmable mRNA platform and executes its clinical strategyBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable mRNA medicines, today announced the more...
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--$ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at more...
Children’s Minnesota Names John Harding as Executive Vice President, Chief Operating Officer
In his role, Harding will provide enterprise-wide operational leadership across the organization’s hospitals, specialty centers and clinics.MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Children’s Minnesota is pleased to announce John Harding, Ed.D., MBA, FACHE, as its new more...
Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
Newly established role strengthens understanding of healthcare clinician needs to help shape the Company’s innovation priorities and portfolio decisionsFORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on more...
Acrobat Genomics Advances to Next Phase of AI-Powered Inhibitor Discovery Program
SAN CARLOS, Calif.--(BUSINESS WIRE)--#AI--Today, Acrobat Genomics (“Acrobat”), a biotechnology company that teaches AI to design proteins using functional data measured directly in human cells, announced the successful completion of Phase I and commencement of expanded more...
Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea
New facility brings deep expertise closer to Asian customers, strengthening Ecolab’s global networkSEOUL, South Korea--(BUSINESS WIRE)--Building on the continued growth and strong performance of its Life Sciences business, Ecolab is further expanding its global bioprocessing more...
Availity® Introduces Availity Extend™ to Power Secure Healthcare Automation at Scale
A direct, network-connected activation layer makes the Availity network buildable and agent-ready—with healthcare-grade security, governance, and trust.JACKSONVILLE, Fla.--(BUSINESS WIRE)--Availity, the nation’s largest healthcare network connecting payers, providers, and technology partners, today unveiled Availity Extend—a new more...
Ashvattha Therapeutics Announces Presentations Highlighting Mechanism of Action for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Migaldendranib (MGB) is a new class of targeted nanomedicine for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with a novel mechanism of action that normalizes VEGF, IL-6, and IL-1β more...
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating more...
New Survey Finds Widespread Mental and Behavioral Health Challenges Among Young Adults and College Students
Findings also highlight differences between student and parent perceptions, as well as the growing role of digital tools in mental health support More than 6 in 10 Americans enrolled in college and young adults ages more...
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
Agreement positions Cellares as a long-term commercial manufacturing partner for rese-cel, enabling thousands of batches per year at a cost per batch that is among the lowest in the industry Cellares’ Cell Shuttle™ and Cell more...
Ludi Announces Ludi Boost™: New AI-Powered Operating Model & Strategic Services Offering for Provider Workforce Management
NASHVILLE, Tenn.--(BUSINESS WIRE)--Ludi, Inc. today announced the launch of Ludi Boost™ — a major operational expansion that integrates AI-enabled compensation tools with a new, strategic provider compensation services offering, giving healthcare organizations of all sizes more...
Prilenia Appoints Dr. Elisabeth Leiderman as Chief Financial Officer
NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--#ALS--Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and Amyotrophic Lateral Sclerosis (ALS), more...
Affinia Therapeutics to Present AFTX-201 for BAG3-Associated Dilated Cardiomyopathy (DCM) and Highlight Proprietary Capsid Engineering and Manufacturing Data at the American Society of Gene & Cell Therapy 2026 Annual Meeting
WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that it will present new preclinical more...